Patent Assignment
Reel/Frame 030231/0808
Assignment of Assignor's Interest
Recorded: 2013-04-17
Pages: 9
Assignor
ABBOTT LABORATORIES
Executed: 2012-08-01
Assignee
ABBVIE INC.
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, ILLINOIS, 60064
Covered Properties
(71)
Modulators and Modulation of the Interaction Between Rgm and Neogenin
DEP2 and Its Uses in Major Depressive Disorder and Other Related Disorders
Substituted 1H-Benzimidazole-4-Carboxamides Are Potent Parp Inhibitors
Methods of Preparation of Recombinant Forms of Human Beta-Amyloid Protein and Uses of These Proteins
Amyloid-Beta Globulomer Antibodies
Anti-ABeta Globulomer 5F7 Antibodies
Anti-Viral Compounds
Anti-Viral Compounds
Anti-Viral Compounds
Crystalline Form of a Drug
Substituted Pyrazolo[3,4-D]Pyrimidines as Protein Kinase Inhibitors
Crystalline N-(4-(4-Aminothieno[2,3-D]Pyrimidin-5-Yl)Phenyl)-N'-(2-Fluoro-5-(Trifluoromethyl)Phenyl)Urea Ethanolate
Crystalline N-(4-(4-Ammoniumthieno[2,3-D]Pyrimidin-5-Yl)Phenyl)-N'-(2-Fluoro-5-(Trifluoromethyl)Phenyl)Urea Benzenesulfonate
Octahydro-Pyrrolo[3,4-B]Pyrrole Derivatives
Novel Acetyl-Coa Carboxylase (Acc) Inhibitors and Their Use in Diabetes, Obesity and Metabolic Syndrome
Novel Acetyl-Coa Carboxylase (Acc) Inhibitors and Their Use in Diabetes, Obesity and Metabolic Syndrome
Pyrazoloquinolones Are Potent Parp Inhibitors
Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme
Indazole Compounds
Process for the Preparation of Indazolyl Ureas That Inhibit Vanilloid SUBTYPE1 (VR1) Receptors
Antagonists of the Vanilloid Receptor Subtype 1 (VR1) and Uses Thereof
Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
Cyclobut-3-Ene-1,2,-Dione Inhibitors of Polo-Like Kinases
Novel Compounds as Cannabinoid Receptor Ligands and Uses Thereof
Novel Compounds as Cannabinoid Receptor Ligands and Uses Thereof
Cyclopropyl Amine Derivatives
Thiazoline and Oxazoline Derivatives and Their Methods of Use
Pyrrole Derivatives and Their Methods of Use
Anti-Infective Agents
Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
Substituted 1H-Benzimidazole-4-Carboxamides Are Potent Parp Inhibitors
Compounds That Inhibit TRPV1 and Uses Thereof
Cytochrome P450 Oxidase Inhibitors and Uses Thereof
Application:
11/846,600 →
Publication:
US 2008/0161246
Novel Compounds as Cannabinoid Receptor Ligands
Novel Compounds as Cannabinoid Receptor Ligands
Treatment of Myeoproliferative Diseases
Interleukin-13 Binding Proteins
Cyclopropyl Amine Derivatives
Anti-Viral Compounds
Aminopyrrolidines as Chemokine Receptor Antagonists
Crystalline Anti-Human Il-12 Antibodies
Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme
Compositions and methods for crystallizing antibodies
Novel Acetyl-Coa Carboxylase (Acc) Inhibitors and Their Use in Diabetes, Obesity and Metabolic Syndrome
Novel Compounds as Cannabinoid Receptor Ligands and Uses Thereof
Substituted 1H-Benzimidazole-4-Carboxamides Are Potent Parp Inhibitors
Antagonists of the Vanilloid Receptor Subtype 1 (VR1) and Uses Thereof
Potent Parp Inhibitors
Anti-Infective Agents
Thiazoline and Oxazoline Derivatives and Their Methods of Use
Octahydro-Pyrrolo[3,4-B]Pyrrole Derivatives
Pyrrole Derivatives and Their Methods of Use
Compounds That Inhibit TRPV1 and Uses Thereof
Anti-Viral Compounds
Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
Application:
12/849,500 →
Publication:
US 2010/0305089
Process for the Preparation of Indazolyl Ureas That Inhibit Vanilloid Subtype 1 (VR1) Receptors
Compositions and Methods of Use of Ritonavir for Treating Hcv
A Method for Treating Cannabinoid Receptor Related Diseases with Cannabinoid Receptor Ligands
Novel Compounds as Cannabinoid Receptor Ligands and Uses Thereof
Combination Therapy with Parp Inhibitors
Application:
13/037,691 →
Publication:
US 2011/0151023
Combination Therapy with Parp Inhibitors
Application:
13/037,712 →
Publication:
US 2011/0152336
Interleukin-13 Binding Proteins
P2X7 Antagonists to Treat Affective Disorders
Application:
13/179,917 →
Publication:
US 2011/0269708
Monoclonal Antibodies Against Amyloid Beta Protein and Uses Thereof
Combination Therapy with Parp Inhibitors
Application:
13/288,165 →
Publication:
US 2012/0045524
Pro-Grp as a Surrogate Marker to Predict and Monitor Response to Bcl-2 Inhibitor Therapy
Application:
13/309,307 →
Publication:
US 2012/0135429
Biomarkers for Identifying Patient Classes
Cytochrome P450 Oxidase Inhibitors and Uses Thereof
Application:
13/315,137 →
Publication:
US 2012/0083490
Combination Therapy With Parp Inhibitors
Application:
13/442,035 →
Publication:
US 2012/0190720
Combination Therapy with Parp Inhibitors
Application:
13/530,232 →
Publication:
US 2012/0264795
Modulators and Modulation of the Interaction Between Rgm and Neogenin
Application:
13/547,109 →
Publication:
US 2013/0101605
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 29, 2006
From: SHATTUCK, DONNA; NEFF, CHRISTOPHER; ABKEVICH, VICTOR; JAMMULAPATI, SRIKANTH
To: MYRIAD GENETICS, INC.
Reel/Frame 018565/0271 →
Assignment of Assignor's Interest
Mar 29, 2007
From: MELLICAN, SEAN M.; LINTON, CATHIE L.; MEI, JIANZHANG; TEDROW, JASON S.
To: ABBOTT LABORATORIES
Reel/Frame 019082/0564 →
Assignment of Assignor's Interest
Mar 29, 2007
From: MELLICAN, SEAN M.; LINTON, CATHIE L.; MEI, JIANZHANG; TEDROW, JASON S.
To: ABBOTT LABORATORIES
Reel/Frame 019082/0780 →
Assignment of Assignor's Interest
Apr 2, 2007
From: GU, YU GUI; WEITZBERG, MOSHE; XU, XIANGDONG; CLARK, RICHARD F.
To: ABBOTT LABORATORIES
Reel/Frame 019099/0417 →
Assignment of Assignor's Interest
Apr 18, 2007
From: TOLLE, JOHN C.; SHEIKH, AHMAD Y
To: ABBOTT LABORATORIES
Reel/Frame 019176/0584 →
Assignment of Assignor's Interest
Apr 20, 2007
From: PENNING, THOMAS D; THOMAS, SHEELA A; ZHU, GUI-DONG; GONG, JIANCHUN
To: ABBOTT LABORATORIES
Reel/Frame 019186/0206 →
Assignment of Assignor's Interest
Apr 24, 2007
From: KATZ, DAVID A.; PACKER, JEREMY C.; BHATHENA, ANAHITA
To: ABBOTT LABORATORIES
Reel/Frame 019202/0260 →
Assignment of Assignor's Interest
May 3, 2007
From: BETEBENNER, DAVID A; DEGOEY, DAVID A; MARING, CLARENCE J; KRUEGAR, ALLAN C
To: ABBOTT LABORATORIES
Reel/Frame 019244/0328 →
Assignment of Assignor's Interest
May 15, 2007
From: SHEPPARD, GEORGE; WANG, GARY; BELL, RANDY; MANTEI, ROBERT
To: ABBOTT LABORATORIES
Reel/Frame 019296/0086 →
Assignment of Assignor's Interest
Jun 6, 2007
From: COWART, MARLON D.; ZHAO, CHEN; SUN, MINGHUA; BLACK, LAWRENCE A.
To: ABBOTT LABORATORIES
Reel/Frame 019389/0940 →
Assignment of Assignor's Interest
Jun 20, 2007
From: BETEBENNER, DAVID A.; MARING, CLARENCE J.; IWASAKI, NOBUHIKO; COOPER, CURT S.
To: ABBOTT LABORATORIES
Reel/Frame 019455/0898 →
Assignment of Assignor's Interest
Jun 20, 2007
From: ROCKWAY, TODD W.; BETEBENNER, DAVID A.; KRUEGER, ALLAN C.; IWASAKI, NOBUHIKO
To: ABBOTT LABORATORIES
Reel/Frame 019456/0338 →
Assignment of Assignor's Interest
Jun 25, 2007
From: GU, YU GUI; XU, XIANGDONG; WEITZBERG, MOSHE; SHAM, HING L.
To: ABBOTT LABORATORIES
Reel/Frame 019471/0971 →
Assignment of Assignor's Interest
Jul 10, 2007
From: PENNING, THOMAS D.; ZHU, GUI-DONG; GANDHI, VIRAJKUMAR B.; GONG, JIANCHUM
To: ABBOTT LABORATORIES
Reel/Frame 019537/0171 →
Assignment of Assignor's Interest
Sep 30, 2008
From: HILLEN, HEINZ; BARGHORN, STEFAN; EBERT, ULRICH M.
To: ABBOTT GMBH & CO. KG
Reel/Frame 021611/0382 →
Assignment of Assignor's Interest
Sep 30, 2008
From: HOLZMAN, THOMAS F.; HARLAN, JOHN E.; EDALJI, ROHINTON; YU, LIPING
To: ABBOTT LABORATORIES
Reel/Frame 021610/0852 →
Assignment of Assignor's Interest
Dec 31, 2008
From: HILLEN, HEINZ; BARGHORN, STEFAN; EBERT, ULRICH M.; STIEBINGER, ANDREAS R.
To: ABBOTT GMBH & CO. KG
Reel/Frame 022046/0955 →
Assignment of Assignor's Interest
Dec 31, 2008
From: LABKOVSKY, BORIS
To: ABBOTT LABORATORIES
Reel/Frame 022046/0918 →
Assignment of Assignor's Interest
Feb 25, 2009
From: BARGHORN, STEFAN; HILLEN, HEINZ; STRIEBINGER, ANDREAS R.; KELLER, PATRICK
To: ABBOTT GMBH & CO. KG
Reel/Frame 022307/0692 →
Assignment of Assignor's Interest
Feb 25, 2009
From: LABKOVSKY, BORIS
To: ABBOTT LABORATORIES
Reel/Frame 022307/0606 →
Corrective Assignment to Correct the <Docket Number> Previously Recorded on Reel 022307 Frame 0606. Assignor(S) Hereby Confirms the <8120USO1> to <8126USO1>.
Feb 26, 2009
From: LABKOVSKY, BORIS
To: ABBOTT LABORATORIES
Reel/Frame 022316/0925 →
Assignment of Assignor's Interest
Jul 16, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030804/0836 →
Security Interest
Dec 27, 2016
From: MYRIAD GENETICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 041198/0578 →
Patent Security Agreement
Jul 7, 2023
From: MYRIAD GENETICS, INC.; MYRIAD WOMEN'S HEALTH, INC.; GATEWAY GENOMICS, LLC; ASSUREX HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 064235/0032 →
Release of Security Interest
Jul 10, 2023
From: JPMORGAN CHASE BANK, N.A.
To: MYRIAD GENETICS, INC.; CRESCENDO BIOSCENCE, INC.; MYRIAD RBM, INC.; MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064239/0091 →